Filter‐Assisted ICP‐MS Tumor Liquid Biopsy Enabled by Dual‐Target‐Regulated Functional DNA Nanospheres Cascade Amplification
Small Methods · 2025-08 · 9 (8)
DOI: 10.1002/smtd.202500314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 22.03.2025. Verfasst von Yiman Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Material Science, Sichuan Normal University, Chengdu, Sichuan, 610068, China. Hauptthemen laut MEDLINE: Nanospheres, Neoplastic Cells, Circulating, Lung Neoplasms, Mass Spectrometry. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University.
Abstract (Originalsprache)
An ultrasensitive ICP‐MS aptasensor is developed utilizing a label‐free, simple filter membrane‐assisted separation technique combined with nucleic acid signal amplification for the analysis of circulating tumor cells (CTCs) in lung cancer clinical samples. The approach is based on the high‐affinity interaction between aptamers and PD‐L1 and mucin 1, which are overexpressed on the cell surface, in conjunction with functional Y‐DNA nanospheres and catalytic hairpin assembly amplifications, enabling the simultaneous detection of two proteins. Additionally, a four‐armed nanostructure with significant spatial site resistance is self‐assembled by introducing streptavidin with biotinylated‐hairpin structures, improving the separation efficiency of the filter membrane. This structural design enables the effective isolation of biotin‐T‐Hg 2+ ‐T and biotin‐C‐Ag + ‐C from free Hg 2+ and Ag + , facilitating highly sensitive dual‐protein detection via ICP‐MS. The limits of detection reached ag mL −1 levels for proteins and single‐cell levels for A549 cells. CTCs are extracted from whole blood samples of lung cancer patients within 45 min through a simple centrifugation procedure. Quantification of CTCs is performed in 37 clinical samples, demonstrating results consistent with clinical diagnoses. The assay exhibits a specificity of 100% and a sensitivity of 94.5%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Material Science, Sichuan Normal University, Chengdu, Sichuan, 610068, China.
- Department of Laboratory Medicine, Med+X Center for Manufacturing, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- Department of Clinical Laboratory Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
ORCID-Profile: Piaopiao Chen
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University
- State Key Laboratory of Respiratory Health and Multimorbidity
- West China Hospital, Sichuan University
- Opening Foundation from Key Lab of Process Analysis and Control of Sichuan Universities
Zitieren
APA
Wu, Y., Wang, Y., Yan, L., Huang, K., Chang, K., & Chen, P. (2025). Filter‐Assisted ICP‐MS Tumor Liquid Biopsy Enabled by Dual‐Target‐Regulated Functional DNA Nanospheres Cascade Amplification. Small Methods, 9(8). https://doi.org/10.1002/smtd.202500314
Vancouver
Wu Y, Wang Y, Yan L, Huang K, Chang K, Chen P. Filter‐Assisted ICP‐MS Tumor Liquid Biopsy Enabled by Dual‐Target‐Regulated Functional DNA Nanospheres Cascade Amplification. Small Methods. 2025;9(8). doi:10.1002/smtd.202500314
BibTeX
@article{Wu2025,
author = {Wu, Yiman and Wang, Yue and Yan, Li and Huang, Ke and Chang, Kai and Chen, Piaopiao},
title = {Filter‐Assisted ICP‐MS Tumor Liquid Biopsy Enabled by Dual‐Target‐Regulated Functional DNA Nanospheres Cascade Amplification},
journal = {Small Methods},
year = {2025},
volume = {9},
number = {8},
doi = {10.1002/smtd.202500314}
}
EUVIMED